nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—Benazepril—Lisinopril—systemic scleroderma	0.435	1	CrCrCtD
Trimipramine—ABCB1—Lisinopril—systemic scleroderma	0.044	0.168	CbGbCtD
Trimipramine—CYP2C9—Leflunomide—systemic scleroderma	0.0432	0.165	CbGbCtD
Trimipramine—ABCB1—Captopril—systemic scleroderma	0.0329	0.126	CbGbCtD
Trimipramine—CYP2D6—Captopril—systemic scleroderma	0.031	0.118	CbGbCtD
Trimipramine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0259	0.099	CbGbCtD
Trimipramine—CYP2C19—Prednisone—systemic scleroderma	0.0257	0.0981	CbGbCtD
Trimipramine—ABCB1—Prednisone—systemic scleroderma	0.0207	0.0791	CbGbCtD
Trimipramine—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0166	0.228	CbGeAlD
Trimipramine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0155	0.0593	CbGbCtD
Trimipramine—CYP2C9—cardial valve—systemic scleroderma	0.0142	0.196	CbGeAlD
Trimipramine—CYP3A4—Prednisone—systemic scleroderma	0.0124	0.0474	CbGbCtD
Trimipramine—ABCB1—Methotrexate—systemic scleroderma	0.0104	0.0397	CbGbCtD
Trimipramine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00669	0.0922	CbGeAlD
Trimipramine—HTR2A—pulmonary artery—systemic scleroderma	0.00474	0.0653	CbGeAlD
Trimipramine—HTR1D—artery—systemic scleroderma	0.00354	0.0487	CbGeAlD
Trimipramine—HTR1D—blood vessel—systemic scleroderma	0.00276	0.0379	CbGeAlD
Trimipramine—HTR2A—artery—systemic scleroderma	0.00176	0.0242	CbGeAlD
Trimipramine—HTR2A—endothelium—systemic scleroderma	0.00148	0.0204	CbGeAlD
Trimipramine—HTR1D—connective tissue—systemic scleroderma	0.00141	0.0194	CbGeAlD
Trimipramine—HTR2A—blood vessel—systemic scleroderma	0.00137	0.0188	CbGeAlD
Trimipramine—HTR3A—digestive system—systemic scleroderma	0.00126	0.0173	CbGeAlD
Trimipramine—HTR3A—lung—systemic scleroderma	0.00105	0.0144	CbGeAlD
Trimipramine—SLC6A4—digestive system—systemic scleroderma	0.000958	0.0132	CbGeAlD
Trimipramine—ABCB1—blood vessel—systemic scleroderma	0.000897	0.0123	CbGeAlD
Trimipramine—SLC6A3—lung—systemic scleroderma	0.000873	0.012	CbGeAlD
Trimipramine—HRH1—connective tissue—systemic scleroderma	0.00084	0.0116	CbGeAlD
Trimipramine—ADRA2A—connective tissue—systemic scleroderma	0.000825	0.0114	CbGeAlD
Trimipramine—SLC6A4—lung—systemic scleroderma	0.0008	0.011	CbGeAlD
Trimipramine—CYP2C19—digestive system—systemic scleroderma	0.000794	0.0109	CbGeAlD
Trimipramine—HRH1—smooth muscle tissue—systemic scleroderma	0.000769	0.0106	CbGeAlD
Trimipramine—SLC6A2—lung—systemic scleroderma	0.000704	0.0097	CbGeAlD
Trimipramine—HTR2A—connective tissue—systemic scleroderma	0.000702	0.00966	CbGeAlD
Trimipramine—HTR2A—smooth muscle tissue—systemic scleroderma	0.000642	0.00884	CbGeAlD
Trimipramine—DRD2—lung—systemic scleroderma	0.000642	0.00884	CbGeAlD
Trimipramine—CYP2C9—digestive system—systemic scleroderma	0.000615	0.00847	CbGeAlD
Trimipramine—HRH1—digestive system—systemic scleroderma	0.000607	0.00836	CbGeAlD
Trimipramine—HRH1—tendon—systemic scleroderma	0.000578	0.00795	CbGeAlD
Trimipramine—ADRA2A—tendon—systemic scleroderma	0.000567	0.00781	CbGeAlD
Trimipramine—HTR2A—digestive system—systemic scleroderma	0.000507	0.00698	CbGeAlD
Trimipramine—HRH1—lung—systemic scleroderma	0.000507	0.00698	CbGeAlD
Trimipramine—ADRA2A—lung—systemic scleroderma	0.000498	0.00685	CbGeAlD
Trimipramine—HTR2A—tendon—systemic scleroderma	0.000482	0.00664	CbGeAlD
Trimipramine—Malaise—Mycophenolic acid—systemic scleroderma	0.000477	0.00208	CcSEcCtD
Trimipramine—Fatigue—Captopril—systemic scleroderma	0.000474	0.00206	CcSEcCtD
Trimipramine—Anxiety—Leflunomide—systemic scleroderma	0.000471	0.00205	CcSEcCtD
Trimipramine—Constipation—Captopril—systemic scleroderma	0.00047	0.00204	CcSEcCtD
Trimipramine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000469	0.00204	CcSEcCtD
Trimipramine—CYP3A4—digestive system—systemic scleroderma	0.000469	0.00646	CbGeAlD
Trimipramine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000468	0.00203	CcSEcCtD
Trimipramine—Dysgeusia—Lisinopril—systemic scleroderma	0.000467	0.00203	CcSEcCtD
Trimipramine—Discomfort—Leflunomide—systemic scleroderma	0.000467	0.00203	CcSEcCtD
Trimipramine—Dry mouth—Leflunomide—systemic scleroderma	0.000462	0.00201	CcSEcCtD
Trimipramine—CYP2D6—digestive system—systemic scleroderma	0.000462	0.00636	CbGeAlD
Trimipramine—Vomiting—Pentoxifylline—systemic scleroderma	0.000461	0.002	CcSEcCtD
Trimipramine—Psychotic disorder—Prednisone—systemic scleroderma	0.000459	0.002	CcSEcCtD
Trimipramine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000459	0.00199	CcSEcCtD
Trimipramine—Rash—Pentoxifylline—systemic scleroderma	0.000457	0.00199	CcSEcCtD
Trimipramine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000457	0.00199	CcSEcCtD
Trimipramine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000457	0.00199	CcSEcCtD
Trimipramine—Headache—Pentoxifylline—systemic scleroderma	0.000454	0.00198	CcSEcCtD
Trimipramine—Feeling abnormal—Captopril—systemic scleroderma	0.000453	0.00197	CcSEcCtD
Trimipramine—Vision blurred—Lisinopril—systemic scleroderma	0.000449	0.00195	CcSEcCtD
Trimipramine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000449	0.00195	CcSEcCtD
Trimipramine—Asthenia—Mometasone—systemic scleroderma	0.000449	0.00195	CcSEcCtD
Trimipramine—Hypotension—Azathioprine—systemic scleroderma	0.000448	0.00195	CcSEcCtD
Trimipramine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00195	CcSEcCtD
Trimipramine—Tremor—Lisinopril—systemic scleroderma	0.000447	0.00194	CcSEcCtD
Trimipramine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000445	0.00194	CcSEcCtD
Trimipramine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000443	0.00193	CcSEcCtD
Trimipramine—Pruritus—Mometasone—systemic scleroderma	0.000443	0.00192	CcSEcCtD
Trimipramine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000442	0.00192	CcSEcCtD
Trimipramine—Tachycardia—Leflunomide—systemic scleroderma	0.000442	0.00192	CcSEcCtD
Trimipramine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000441	0.00192	CcSEcCtD
Trimipramine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000436	0.00189	CcSEcCtD
Trimipramine—Abdominal pain—Captopril—systemic scleroderma	0.000434	0.00189	CcSEcCtD
Trimipramine—Body temperature increased—Captopril—systemic scleroderma	0.000434	0.00189	CcSEcCtD
Trimipramine—Oedema—Mycophenolic acid—systemic scleroderma	0.000432	0.00188	CcSEcCtD
Trimipramine—Anorexia—Leflunomide—systemic scleroderma	0.000432	0.00188	CcSEcCtD
Trimipramine—Nausea—Pentoxifylline—systemic scleroderma	0.000431	0.00187	CcSEcCtD
Trimipramine—Malaise—Lisinopril—systemic scleroderma	0.00043	0.00187	CcSEcCtD
Trimipramine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00186	CcSEcCtD
Trimipramine—Diarrhoea—Mometasone—systemic scleroderma	0.000428	0.00186	CcSEcCtD
Trimipramine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00184	CcSEcCtD
Trimipramine—HTR2A—lung—systemic scleroderma	0.000423	0.00583	CbGeAlD
Trimipramine—Hypotension—Leflunomide—systemic scleroderma	0.000423	0.00184	CcSEcCtD
Trimipramine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000423	0.00184	CcSEcCtD
Trimipramine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000422	0.00183	CcSEcCtD
Trimipramine—Palpitations—Lisinopril—systemic scleroderma	0.000421	0.00183	CcSEcCtD
Trimipramine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000412	0.00179	CcSEcCtD
Trimipramine—Insomnia—Leflunomide—systemic scleroderma	0.00041	0.00178	CcSEcCtD
Trimipramine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00178	CcSEcCtD
Trimipramine—Paraesthesia—Leflunomide—systemic scleroderma	0.000407	0.00177	CcSEcCtD
Trimipramine—Anxiety—Lisinopril—systemic scleroderma	0.000404	0.00176	CcSEcCtD
Trimipramine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000404	0.00176	CcSEcCtD
Trimipramine—Discomfort—Lisinopril—systemic scleroderma	0.000401	0.00174	CcSEcCtD
Trimipramine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000401	0.00174	CcSEcCtD
Trimipramine—Dyspepsia—Leflunomide—systemic scleroderma	0.000399	0.00173	CcSEcCtD
Trimipramine—Vomiting—Mometasone—systemic scleroderma	0.000398	0.00173	CcSEcCtD
Trimipramine—Dry mouth—Lisinopril—systemic scleroderma	0.000397	0.00173	CcSEcCtD
Trimipramine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000395	0.00172	CcSEcCtD
Trimipramine—Rash—Mometasone—systemic scleroderma	0.000394	0.00172	CcSEcCtD
Trimipramine—Asthenia—Captopril—systemic scleroderma	0.000394	0.00171	CcSEcCtD
Trimipramine—Dermatitis—Mometasone—systemic scleroderma	0.000394	0.00171	CcSEcCtD
Trimipramine—Decreased appetite—Leflunomide—systemic scleroderma	0.000394	0.00171	CcSEcCtD
Trimipramine—Confusional state—Lisinopril—systemic scleroderma	0.000392	0.00171	CcSEcCtD
Trimipramine—Headache—Mometasone—systemic scleroderma	0.000392	0.0017	CcSEcCtD
Trimipramine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000391	0.0017	CcSEcCtD
Trimipramine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000391	0.0017	CcSEcCtD
Trimipramine—Fatigue—Leflunomide—systemic scleroderma	0.00039	0.0017	CcSEcCtD
Trimipramine—Oedema—Lisinopril—systemic scleroderma	0.000389	0.00169	CcSEcCtD
Trimipramine—Pruritus—Captopril—systemic scleroderma	0.000389	0.00169	CcSEcCtD
Trimipramine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000388	0.00169	CcSEcCtD
Trimipramine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00169	CcSEcCtD
Trimipramine—Constipation—Leflunomide—systemic scleroderma	0.000387	0.00168	CcSEcCtD
Trimipramine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000384	0.00167	CcSEcCtD
Trimipramine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000384	0.00167	CcSEcCtD
Trimipramine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000381	0.00166	CcSEcCtD
Trimipramine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00038	0.00165	CcSEcCtD
Trimipramine—Tachycardia—Lisinopril—systemic scleroderma	0.00038	0.00165	CcSEcCtD
Trimipramine—Abdominal pain—Azathioprine—systemic scleroderma	0.000379	0.00165	CcSEcCtD
Trimipramine—Body temperature increased—Azathioprine—systemic scleroderma	0.000379	0.00165	CcSEcCtD
Trimipramine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000377	0.00164	CcSEcCtD
Trimipramine—Diarrhoea—Captopril—systemic scleroderma	0.000376	0.00164	CcSEcCtD
Trimipramine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000376	0.00163	CcSEcCtD
Trimipramine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000374	0.00163	CcSEcCtD
Trimipramine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000373	0.00162	CcSEcCtD
Trimipramine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000372	0.00162	CcSEcCtD
Trimipramine—Nausea—Mometasone—systemic scleroderma	0.000372	0.00162	CcSEcCtD
Trimipramine—Anorexia—Lisinopril—systemic scleroderma	0.000371	0.00161	CcSEcCtD
Trimipramine—Weight increased—Prednisone—systemic scleroderma	0.00037	0.00161	CcSEcCtD
Trimipramine—Ataxia—Methotrexate—systemic scleroderma	0.000369	0.00161	CcSEcCtD
Trimipramine—Constipation—Mycophenolic acid—systemic scleroderma	0.000369	0.00161	CcSEcCtD
Trimipramine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000369	0.00161	CcSEcCtD
Trimipramine—Hypotension—Lisinopril—systemic scleroderma	0.000364	0.00158	CcSEcCtD
Trimipramine—Dizziness—Captopril—systemic scleroderma	0.000363	0.00158	CcSEcCtD
Trimipramine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00157	CcSEcCtD
Trimipramine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00157	CcSEcCtD
Trimipramine—Urticaria—Leflunomide—systemic scleroderma	0.00036	0.00156	CcSEcCtD
Trimipramine—Abdominal pain—Leflunomide—systemic scleroderma	0.000358	0.00156	CcSEcCtD
Trimipramine—Body temperature increased—Leflunomide—systemic scleroderma	0.000358	0.00156	CcSEcCtD
Trimipramine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000357	0.00155	CcSEcCtD
Trimipramine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000356	0.00155	CcSEcCtD
Trimipramine—Myocardial infarction—Prednisone—systemic scleroderma	0.000355	0.00154	CcSEcCtD
Trimipramine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000355	0.00154	CcSEcCtD
Trimipramine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00154	CcSEcCtD
Trimipramine—Insomnia—Lisinopril—systemic scleroderma	0.000352	0.00153	CcSEcCtD
Trimipramine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000351	0.00153	CcSEcCtD
Trimipramine—Paraesthesia—Lisinopril—systemic scleroderma	0.000349	0.00152	CcSEcCtD
Trimipramine—Vomiting—Captopril—systemic scleroderma	0.000349	0.00152	CcSEcCtD
Trimipramine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000348	0.00151	CcSEcCtD
Trimipramine—Rash—Captopril—systemic scleroderma	0.000346	0.00151	CcSEcCtD
Trimipramine—Dermatitis—Captopril—systemic scleroderma	0.000346	0.00151	CcSEcCtD
Trimipramine—Somnolence—Lisinopril—systemic scleroderma	0.000346	0.0015	CcSEcCtD
Trimipramine—Headache—Captopril—systemic scleroderma	0.000344	0.0015	CcSEcCtD
Trimipramine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000344	0.0015	CcSEcCtD
Trimipramine—Dyspepsia—Lisinopril—systemic scleroderma	0.000343	0.00149	CcSEcCtD
Trimipramine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000341	0.00149	CcSEcCtD
Trimipramine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000341	0.00149	CcSEcCtD
Trimipramine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00148	CcSEcCtD
Trimipramine—Decreased appetite—Lisinopril—systemic scleroderma	0.000338	0.00147	CcSEcCtD
Trimipramine—Eosinophilia—Methotrexate—systemic scleroderma	0.000336	0.00146	CcSEcCtD
Trimipramine—Fatigue—Lisinopril—systemic scleroderma	0.000335	0.00146	CcSEcCtD
Trimipramine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00145	CcSEcCtD
Trimipramine—Constipation—Lisinopril—systemic scleroderma	0.000333	0.00145	CcSEcCtD
Trimipramine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00145	CcSEcCtD
Trimipramine—ABCB1—digestive system—systemic scleroderma	0.000332	0.00457	CbGeAlD
Trimipramine—Diarrhoea—Azathioprine—systemic scleroderma	0.000328	0.00143	CcSEcCtD
Trimipramine—Nausea—Captopril—systemic scleroderma	0.000326	0.00142	CcSEcCtD
Trimipramine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00141	CcSEcCtD
Trimipramine—Asthenia—Leflunomide—systemic scleroderma	0.000325	0.00141	CcSEcCtD
Trimipramine—Hallucination—Prednisone—systemic scleroderma	0.000324	0.00141	CcSEcCtD
Trimipramine—Pancytopenia—Methotrexate—systemic scleroderma	0.000323	0.0014	CcSEcCtD
Trimipramine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000321	0.00139	CcSEcCtD
Trimipramine—Pruritus—Leflunomide—systemic scleroderma	0.00032	0.00139	CcSEcCtD
Trimipramine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000319	0.00139	CcSEcCtD
Trimipramine—Dizziness—Azathioprine—systemic scleroderma	0.000317	0.00138	CcSEcCtD
Trimipramine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000313	0.00136	CcSEcCtD
Trimipramine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00031	0.00135	CcSEcCtD
Trimipramine—Diarrhoea—Leflunomide—systemic scleroderma	0.00031	0.00135	CcSEcCtD
Trimipramine—Urticaria—Lisinopril—systemic scleroderma	0.000309	0.00134	CcSEcCtD
Trimipramine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00134	CcSEcCtD
Trimipramine—Abdominal pain—Lisinopril—systemic scleroderma	0.000308	0.00134	CcSEcCtD
Trimipramine—Body temperature increased—Lisinopril—systemic scleroderma	0.000308	0.00134	CcSEcCtD
Trimipramine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000306	0.00133	CcSEcCtD
Trimipramine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000306	0.00133	CcSEcCtD
Trimipramine—Vomiting—Azathioprine—systemic scleroderma	0.000305	0.00133	CcSEcCtD
Trimipramine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00132	CcSEcCtD
Trimipramine—Drowsiness—Methotrexate—systemic scleroderma	0.000303	0.00132	CcSEcCtD
Trimipramine—Rash—Azathioprine—systemic scleroderma	0.000302	0.00132	CcSEcCtD
Trimipramine—Dermatitis—Azathioprine—systemic scleroderma	0.000302	0.00131	CcSEcCtD
Trimipramine—Flushing—Prednisone—systemic scleroderma	0.000302	0.00131	CcSEcCtD
Trimipramine—Headache—Azathioprine—systemic scleroderma	0.0003	0.00131	CcSEcCtD
Trimipramine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.0003	0.00131	CcSEcCtD
Trimipramine—Dizziness—Leflunomide—systemic scleroderma	0.000299	0.0013	CcSEcCtD
Trimipramine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00129	CcSEcCtD
Trimipramine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000296	0.00129	CcSEcCtD
Trimipramine—Stomatitis—Methotrexate—systemic scleroderma	0.000295	0.00128	CcSEcCtD
Trimipramine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000292	0.00127	CcSEcCtD
Trimipramine—Arrhythmia—Prednisone—systemic scleroderma	0.000291	0.00126	CcSEcCtD
Trimipramine—Vomiting—Leflunomide—systemic scleroderma	0.000288	0.00125	CcSEcCtD
Trimipramine—Alopecia—Prednisone—systemic scleroderma	0.000287	0.00125	CcSEcCtD
Trimipramine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000286	0.00124	CcSEcCtD
Trimipramine—Rash—Leflunomide—systemic scleroderma	0.000286	0.00124	CcSEcCtD
Trimipramine—Dermatitis—Leflunomide—systemic scleroderma	0.000285	0.00124	CcSEcCtD
Trimipramine—Nausea—Azathioprine—systemic scleroderma	0.000285	0.00124	CcSEcCtD
Trimipramine—Headache—Leflunomide—systemic scleroderma	0.000284	0.00123	CcSEcCtD
Trimipramine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000283	0.00123	CcSEcCtD
Trimipramine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000281	0.00122	CcSEcCtD
Trimipramine—Asthenia—Lisinopril—systemic scleroderma	0.000279	0.00121	CcSEcCtD
Trimipramine—ABCB1—lung—systemic scleroderma	0.000277	0.00382	CbGeAlD
Trimipramine—Pruritus—Lisinopril—systemic scleroderma	0.000275	0.0012	CcSEcCtD
Trimipramine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000275	0.00119	CcSEcCtD
Trimipramine—Rash—Mycophenolic acid—systemic scleroderma	0.000272	0.00118	CcSEcCtD
Trimipramine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000272	0.00118	CcSEcCtD
Trimipramine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000271	0.00118	CcSEcCtD
Trimipramine—Headache—Mycophenolic acid—systemic scleroderma	0.000271	0.00118	CcSEcCtD
Trimipramine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00117	CcSEcCtD
Trimipramine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00117	CcSEcCtD
Trimipramine—Nausea—Leflunomide—systemic scleroderma	0.000269	0.00117	CcSEcCtD
Trimipramine—Vision blurred—Prednisone—systemic scleroderma	0.000267	0.00116	CcSEcCtD
Trimipramine—Diarrhoea—Lisinopril—systemic scleroderma	0.000266	0.00116	CcSEcCtD
Trimipramine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000263	0.00114	CcSEcCtD
Trimipramine—Agitation—Prednisone—systemic scleroderma	0.00026	0.00113	CcSEcCtD
Trimipramine—Dizziness—Lisinopril—systemic scleroderma	0.000257	0.00112	CcSEcCtD
Trimipramine—Nausea—Mycophenolic acid—systemic scleroderma	0.000257	0.00112	CcSEcCtD
Trimipramine—Malaise—Prednisone—systemic scleroderma	0.000255	0.00111	CcSEcCtD
Trimipramine—Tinnitus—Methotrexate—systemic scleroderma	0.000253	0.0011	CcSEcCtD
Trimipramine—Vomiting—Lisinopril—systemic scleroderma	0.000247	0.00108	CcSEcCtD
Trimipramine—Rash—Lisinopril—systemic scleroderma	0.000245	0.00107	CcSEcCtD
Trimipramine—Convulsion—Prednisone—systemic scleroderma	0.000245	0.00107	CcSEcCtD
Trimipramine—Dermatitis—Lisinopril—systemic scleroderma	0.000245	0.00107	CcSEcCtD
Trimipramine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00106	CcSEcCtD
Trimipramine—Hypertension—Prednisone—systemic scleroderma	0.000244	0.00106	CcSEcCtD
Trimipramine—Headache—Lisinopril—systemic scleroderma	0.000244	0.00106	CcSEcCtD
Trimipramine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00105	CcSEcCtD
Trimipramine—Anxiety—Prednisone—systemic scleroderma	0.00024	0.00104	CcSEcCtD
Trimipramine—Alopecia—Methotrexate—systemic scleroderma	0.00024	0.00104	CcSEcCtD
Trimipramine—Discomfort—Prednisone—systemic scleroderma	0.000238	0.00104	CcSEcCtD
Trimipramine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00101	CcSEcCtD
Trimipramine—Dysgeusia—Methotrexate—systemic scleroderma	0.000232	0.00101	CcSEcCtD
Trimipramine—Nausea—Lisinopril—systemic scleroderma	0.000231	0.00101	CcSEcCtD
Trimipramine—Oedema—Prednisone—systemic scleroderma	0.000231	0.00101	CcSEcCtD
Trimipramine—Tachycardia—Prednisone—systemic scleroderma	0.000226	0.000981	CcSEcCtD
Trimipramine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000981	CcSEcCtD
Trimipramine—Vision blurred—Methotrexate—systemic scleroderma	0.000223	0.00097	CcSEcCtD
Trimipramine—Anorexia—Prednisone—systemic scleroderma	0.00022	0.000958	CcSEcCtD
Trimipramine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00022	0.000955	CcSEcCtD
Trimipramine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000943	CcSEcCtD
Trimipramine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000935	CcSEcCtD
Trimipramine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000934	CcSEcCtD
Trimipramine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000929	CcSEcCtD
Trimipramine—Malaise—Methotrexate—systemic scleroderma	0.000213	0.000928	CcSEcCtD
Trimipramine—Insomnia—Prednisone—systemic scleroderma	0.000209	0.000909	CcSEcCtD
Trimipramine—Paraesthesia—Prednisone—systemic scleroderma	0.000208	0.000903	CcSEcCtD
Trimipramine—Convulsion—Methotrexate—systemic scleroderma	0.000205	0.000892	CcSEcCtD
Trimipramine—Dyspepsia—Prednisone—systemic scleroderma	0.000203	0.000885	CcSEcCtD
Trimipramine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000881	CcSEcCtD
Trimipramine—Decreased appetite—Prednisone—systemic scleroderma	0.000201	0.000874	CcSEcCtD
Trimipramine—Fatigue—Prednisone—systemic scleroderma	0.000199	0.000867	CcSEcCtD
Trimipramine—Discomfort—Methotrexate—systemic scleroderma	0.000199	0.000866	CcSEcCtD
Trimipramine—Constipation—Prednisone—systemic scleroderma	0.000198	0.00086	CcSEcCtD
Trimipramine—Confusional state—Methotrexate—systemic scleroderma	0.000195	0.000847	CcSEcCtD
Trimipramine—Feeling abnormal—Prednisone—systemic scleroderma	0.00019	0.000828	CcSEcCtD
Trimipramine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000189	0.000822	CcSEcCtD
Trimipramine—Anorexia—Methotrexate—systemic scleroderma	0.000184	0.000801	CcSEcCtD
Trimipramine—Urticaria—Prednisone—systemic scleroderma	0.000184	0.000798	CcSEcCtD
Trimipramine—Abdominal pain—Prednisone—systemic scleroderma	0.000183	0.000795	CcSEcCtD
Trimipramine—Body temperature increased—Prednisone—systemic scleroderma	0.000183	0.000795	CcSEcCtD
Trimipramine—Hypotension—Methotrexate—systemic scleroderma	0.00018	0.000785	CcSEcCtD
Trimipramine—Insomnia—Methotrexate—systemic scleroderma	0.000175	0.00076	CcSEcCtD
Trimipramine—Paraesthesia—Methotrexate—systemic scleroderma	0.000173	0.000754	CcSEcCtD
Trimipramine—Somnolence—Methotrexate—systemic scleroderma	0.000172	0.000747	CcSEcCtD
Trimipramine—Dyspepsia—Methotrexate—systemic scleroderma	0.00017	0.000739	CcSEcCtD
Trimipramine—Decreased appetite—Methotrexate—systemic scleroderma	0.000168	0.00073	CcSEcCtD
Trimipramine—Fatigue—Methotrexate—systemic scleroderma	0.000167	0.000724	CcSEcCtD
Trimipramine—Asthenia—Prednisone—systemic scleroderma	0.000166	0.000721	CcSEcCtD
Trimipramine—Pruritus—Prednisone—systemic scleroderma	0.000163	0.000711	CcSEcCtD
Trimipramine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000159	0.000692	CcSEcCtD
Trimipramine—Diarrhoea—Prednisone—systemic scleroderma	0.000158	0.000688	CcSEcCtD
Trimipramine—Benazepril—ACE—systemic scleroderma	0.000157	1	CrCbGaD
Trimipramine—Urticaria—Methotrexate—systemic scleroderma	0.000153	0.000667	CcSEcCtD
Trimipramine—Dizziness—Prednisone—systemic scleroderma	0.000153	0.000665	CcSEcCtD
Trimipramine—Abdominal pain—Methotrexate—systemic scleroderma	0.000153	0.000664	CcSEcCtD
Trimipramine—Body temperature increased—Methotrexate—systemic scleroderma	0.000153	0.000664	CcSEcCtD
Trimipramine—Vomiting—Prednisone—systemic scleroderma	0.000147	0.000639	CcSEcCtD
Trimipramine—Rash—Prednisone—systemic scleroderma	0.000146	0.000634	CcSEcCtD
Trimipramine—Dermatitis—Prednisone—systemic scleroderma	0.000146	0.000633	CcSEcCtD
Trimipramine—Headache—Prednisone—systemic scleroderma	0.000145	0.00063	CcSEcCtD
Trimipramine—Asthenia—Methotrexate—systemic scleroderma	0.000139	0.000603	CcSEcCtD
Trimipramine—Nausea—Prednisone—systemic scleroderma	0.000137	0.000597	CcSEcCtD
Trimipramine—Pruritus—Methotrexate—systemic scleroderma	0.000137	0.000594	CcSEcCtD
Trimipramine—Diarrhoea—Methotrexate—systemic scleroderma	0.000132	0.000575	CcSEcCtD
Trimipramine—Dizziness—Methotrexate—systemic scleroderma	0.000128	0.000555	CcSEcCtD
Trimipramine—Vomiting—Methotrexate—systemic scleroderma	0.000123	0.000534	CcSEcCtD
Trimipramine—Rash—Methotrexate—systemic scleroderma	0.000122	0.00053	CcSEcCtD
Trimipramine—Dermatitis—Methotrexate—systemic scleroderma	0.000122	0.000529	CcSEcCtD
Trimipramine—Headache—Methotrexate—systemic scleroderma	0.000121	0.000526	CcSEcCtD
Trimipramine—Nausea—Methotrexate—systemic scleroderma	0.000115	0.000499	CcSEcCtD
